Brief: AN2 Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results And Recent Highlights
29/03/2023 21:33
March 29 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* AN2 THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND RECENT HIGHLIGHTS
* AN2 THERAPEUTICS- CASH, CASH EQUIVALENTS, INVESTMENTS OF
$99.3
MILLION AT DEC 31, 2022 WHICH CO EXPECTS AS SUFFICIENT TO FUND
EXPENSES THROUGH MID-2024
Source text for Eikon: ID:nBwbRZSSha
Further company coverage: ANTX.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview